Morgan Stanton is the CEO and Founder of Opal Therapeutics, a biotech company pioneering drug discovery for womens reproductive health. With a Ph. D. in Chemistry from Worcester Polytechnic Institute, she leverages her deep expertise in tissue engineering and organoid models to develop novel therapeutics for chronic gynecological disorders.
Her passion for this field is deeply personal, sparked by her own challenging five-year journey with uterine fibroids. This experience fuels her mission to address the significant research and funding gaps in womens health, aiming to develop more effective and less invasive treatments for conditions like endometriosis and fibroids.
To advance her research, she created a unique biobank collection method, personally acting as a courier to pick up menstrual samples from donors around the Bay Area.
Read the full overview →They prefer to analyze every situation thoroughly. They are more likely than others to negotiate on pricing and terms. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.